1. Adsorption of Thiotepa anticancer drugs on the BC 3 nanotube as a promising nanocarriers for drug delivery.
- Author
-
Al-Hetty HRAK, Al-Lami MS, Jawad SF, Waleed I, Muttashar HH, Mohamed AMA, Kadhim MM, and Derakhshandeh M
- Subjects
- Adsorption, Thiotepa, Water, Antineoplastic Agents chemistry, Nanotubes chemistry
- Abstract
By applying periodic DFT computations, the possible employment of BC
3 nanotube (BC3 NT) as a drug delivery system (DDS) for Thiotepa (TPA) anticancer medicine has been examined. Quantum mechanics computations by the B3LYP-6-31 +G(d,p) method with dispersion correction including to be used for calculation the details of electronic, geometric, and energetic features of the interactions between TPA drug and BC3 NT. The appropriate orientation for the TPA interacting with BC3 NT has been assessed and adsorption energies (ΔEad ) have been computed. The band distance of S and B atom in complex C2 is about 1.89 Å, also the value of ΔEad of - 29.83 kcal/mol in most stable compounds. By applying frontier molecular orbital analysis, it has been assessed that during stimulation, TPA medicine performs as HOMO and delivers the charge towards the LUMO, i.e., BC3 NT. In the aqueous phase, the λmax of BC3 NT-AP complex is blue-shifted by 36 nm. Drug delivery to the specific cells after protonation has been studied, due to the point that cancer cells have lower pH than others. The value of computed solvation energy (ΔEsolvation ) shows the solubility BC3 NT@TPA system in the water phase. The effects of the present investigation verified the ability of BC3 NT as a drug delivery agent for TPA in the treatment of cancer., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF